1. Volume 64, Issue 3, Pages 601-608 (March 2016)
Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems 
Po-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, Yun-Hsuan Lee, Chien-Wei Su, Yi-Hsiang Huang, Fa-Yauh Lee, Han-Chieh Lin, Teh-Ia Huo 
Journal of Hepatology 
Volume 64, Issue 3, Pages (March 2016)
DOI: /j.jhep
Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

2. Journal of Hepatology 2016 64, 601-608DOI: (10. 1016/j. jhep. 2015. 10
Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

3. Fig. 1
Distribution of patients in 11 staging systems for hepatocellular carcinoma.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

4. Fig. 2
Comparison of survival distributions by (A) BCLC, (B) HKLC, (C) CLIP, (D) TIS, (E) JIS, and (F) Tokyo staging systems. There were significant differences in survival distributions between all adjacent stages except between HKLC stage IV/V, JIS score 4/5, and Tokyo score 5 through 8. BCLC, Barcelona Clínic Liver Cancer; HKLC, Hong Kong Liver Cancer; CLIP, Cancer of the Liver Italian Program; TIS, Taipei Integrated Scoring System; JIS, Japan Integrated Staging. (This figure appears in colour on the web.)
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2015 European Association for the Study of the Liver Terms and Conditions

5. Fig. 3
Comparison of survival distributions by (A) AJCC TNM-7, (B) TNM by LCSGJ, (C) Okuda, (D) CUPI, and (E) French staging systems. Significant differences in survival were found between all adjacent stages. AJCC, American Joint Committee on Cancer; TNM, Tumor-Node-Metastasis; LCSGJ, Liver Cancer Study Group of Japan; CUPI, Chinese University Prognostic Index. (This figure appears in colour on the web.)
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2015 European Association for the Study of the Liver Terms and Conditions